About Index Trending news
Analyze
Top 50 Pricing
Nuo Therapeutics

Nuo Therapeutics

Work at Nuo Therapeutics? Add yourself to this profile

Nuo Therapeutics

Cytomedix develops biological therapies to address the areas of wound care,inflammation and angiogenesis.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$7,500,000
Employees

Team size

10+
Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Nuo Therapeutics makes some noise.